Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Cappello, M. Carbone, I. Gnemmi, C. Vicari, G. Caramori, A. Zanini, A. Capelli, G. La Rocca, R. Anzalone, S. E. D‘Anna, F. L. M. Ricciardolo, P. Brun, B. Balbi, M. Carone, G. Zummo, E. C. de Macario, A. J. L. Macario, A. Di Stefano (Veruno, Tradate and Cassano, Padova, Cefalù (PA), Italy; Baltimore, United States Of America). Hsp10, Hsp40 and Hsp60 increase in the bronchial mucosa of patients with severe chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 1799

Member's Comments

No comment yet.

Related content which might interest you: Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 "Nitosative stress" in the bronchial mucosa of severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 363s Year: 2005 Expression of heat shock proteins in chronic obstructive pulmonary disease, vernal keratoconjunctivitis and ulcerative colitis Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Association of extracellular Hsp70 with the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Markers of difference of severe bronchial asthma and chronic obstructive diseases of lungs with irreversible obstruction Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005